News | August 02, 2024
GlaxoSmithKline Pharmaceuticals reports Q1 FY25 PAT at Rs. 182 Cr
Strong topline growth driven by solid performance across key brands.
Strong topline growth driven by solid performance across key brands.
The drug will be manufactured at the group's formulation manufacturing facility in Ahmedabad SEZ - II, India
Sacubitril and Valsartan Tablets are indicated to reduce the risk of cardiovascular death
_256_384.jpeg)
ASG Group of Eye Hospitals has 165+ branches in 85+ cities across India and abroad
Under the arrangement, Dr. Reddy's will have exclusive rights to promote and distribute Sanofi's vaccine brands Hexaxim, Pentaxim, Tetraxim, Menactra, FluQuadri, Adacel and Avaxim 80U
The approved product has an estimated market size of US$ 44.5 million for the twelve months ending January 2024
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
Dr. Mandaviya also laid the foundation stone for an All India Institute of Speech and Hearing (AIISH) Satellite Centre in Kanpur
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure
Receives registration of Valganciclovir powder for oral solution in Germany
Subscribe To Our Newsletter & Stay Updated
